Our Pfizer (PFE) Feb Week Four (2/26) 35 Call is on track to expire worthless. I will recommend a new call to sell against shares soon. The stock’s inability to move higher is frustrating, to say the least. But shares are grossly undervalued, and I plan to trade PFE for an extended period of time.…
I was hoping for a bounce in Pfizer (PFE) that did not happen. Let’s sell a call on our uncovered shares to reduce our cost basis. Current Stock Price: $34.41 Cost Basis: $37.96 Action: Sell to open the PFE Feb Week Four (2/26) 35 Call for around $0.39 New Cost Basis: $37.57
Our Pfizer (PFE) Feb Week One (2/5) 38 Call is on track to expire worthless. I will recommend a new call to sell against shares next week. Current Stock Price: $34.95 Cost Basis: $37.96 Action: Watch call expire worthless
I am recommending we book profits on our General Motors (GM), Pfizer (PFE), QuantumScape (QS) and Twitter (TWTR) positions. Given the recent bouts of unexpected volatility, this is the smart move. And since we are freeing up a lot of capital with these closeouts, it’s possible I will open new positions via alert. So, keep…
Below are the trades I recommended in today’s Options Income Blueprint Live Trading Session. You can watch a recording of the session here. Note that option prices may have moved since the Live Trading Session. Please do not chase the trades by accepting less premium than the “go as low as” price recommended below. Work…
Pfizer (PFE) was unable to break through $37.50 this week and turned lower. The company is expected to announce earnings next week. I am recommending a call to sell on our uncovered shares in the hope that we will get called out around breakeven. Current Stock Price: $36.35 Cost Basis: $38.26 Action: Sell to open…
Our Pfizer (PFE) Jan Week Four (1/22) 37.50 Call is on track to expire worthless. I will recommend another call to sell soon to continue to reduce our net debit. Current Stock Price: $36.36 Cost Basis: $38.26 Action: Watch call expire worthless
Our Pfizer (PFE) Jan Week Four (1/22) 37.50 Call is on track to expire worthless. I will recommend another call to sell soon to continue to reduce our net debit. Current Stock Price: $36.36 Cost Basis: $38.26 Action: Watch call expire worthless
Pfizer (PFE) was unable to punch through $37.50 this week. I am recommending we sell a call at that level to bring in income and reduce our cost basis on the position. Current Stock Price: $36.80 Cost Basis: $38.65 Action: Sell to open the PFE Jan Week Four (1/22) 37.50 Call for around $0.39 New…
Our Pfizer (PFE) Jan Week Two (1/8) 40 Put is deep in the money, so I am recommending we accept shares. We will sell a call against them next week to reduce our cost basis. Current Stock Price: $37.33 Cash in Hand: $1.35 Action: Accept shares Cost Basis: $38.65
